Ambry Genetics Pays $700,000 Penalty to Settle HIPAA Violations
Ambry Genetics, a California-based genetic testing company, has agreed to pay $700,000 to settle HIPAA violations with the HHS Office for Civil Rights. The settlement resolves findings related to the company's handling of protected health information.
Why this matters: Genetic data is not like a leaked email address. It is permanent, inherited, and shared with biological relatives who never agreed to anything. When a genetics company mishandles HIPAA obligations, the people exposed cannot change their DNA to fix the problem. A $700,000 penalty sounds significant until you consider what this data is worth and what its exposure can cost people in insurance, employment, or just peace of mind. Regulators need to make these penalties sting enough to change behavior, not just close the file.
Who should care: Lawyers · Privacy officers · Compliance · Healthcare professionals
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.